You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK):阿託伐他汀鈣片獲批准上市
格隆匯 06-28 18:42

格隆匯6月28日丨東陽光藥(01558.HK)發佈公吿,公司自廣東東陽光藥業有限公司收購的產品阿託伐他汀鈣片(10mg、20mg及40mg)已獲中國國家藥品監督管理局審批完畢並獲准上市。該產品的上市許可持有人為公司的全資子公司陽之康。

阿託伐他汀鈣適用於高膽固醇血癥,有助降低非致死性心肌梗死的風險、致死性和非致死性卒中的風險、血管重建術的風險、因充血性心力衰竭而住院的風險以及心絞痛的風險。阿託伐他汀鈣通過抑制肝臟內HMG-CoA還原酶及膽固醇的合成而降低血漿膽固醇和脂蛋白水平,並通過增加肝臟細胞表面的LDL受體數以增強低密度脂蛋白的攝取和分解代謝。

該產品為中國境內獲批准上市的仿製藥,獲批准上市後即為視同通過仿製藥質量和療效一致性評價的產品;該產品具有良好的臨牀應用價值和市場前景,上市後將成為公司在心血管疾病治療領域的產品之一,在進一步豐富集團的產品組合的同時,也為廣大患者提供質價雙優的用藥選擇。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account